News

AlphaFold 3, CRISPR Eyes, Ear Genes, MDMA, Societal Collapse (Not Boring)

Packy McCormick's Weekly Dose of Optimism gives highlights of the SynBioBeta 2024 annual conference

"We are living in an age of miracles."

Democratize Omics Data Analysis with Basepair on AWS HealthOmics (Amazon)

Amazon Web Services' focus on genomics (and proteomics, transcriptomics, etc.) is evidence that the industry is digital and big.

Personal Hygiene’s Renaissance, Brought to You by Synthetic Biology (SynBioBeta)

"[I]t’s so delightful that Taxa Technologies will be using synthetic biology to get their consumers closer to nature, not further. In other words, they’ll be leveraging synthetic biology to deliver products that are actually less synthetic"

Synthetic Biology Market Experiencing Rapid Growth 28.3% (BioSpace)

"The synthetic biology market is experiencing rapid growth driven by its diverse applications across medicine, manufacturing, and agriculture."

Patenting Considerations for Life Science Companies (Life Sciences Review)

"Many business people conceptually associate their patents with their products. That is a dangerous view."

5 Startup Opportunities In Genomics (Forbes)

"The ability to read, interpret, and manipulate genetic information is not just transforming medicine by offering the potential to eliminate diseases and increase human lifespan - it's paving the way for entirely new industries."

Gene Therapy, DNA's Past, RNA's Future: A Time Of Promise (Forbes)

"With continued research and development, gene therapy can transform countless lives."

Seed stage is about picking winners (OpenVC)

"Portfolio concentration should be proportional to knowledge"

Proteomics sets up single-cell and single-molecule solutions (Nature Methods)

"The future is not one in which every biologist has to be a mass spectrometrist"